Efficacy, Safety, and Tolerability Study of Infliximab in Juvenile Spondyloarthropathies

NCT00591201 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

26

Enrollment

OTHER_GOV

Sponsor class

Conditions

Spondylarthropathies

Interventions

DRUG: infliximab
DRUG: Placebo

Sponsor

Hospital General de Mexico

Collaborators

[object Object]